Investor
Cornucopian Capital
Cornucopian Capital provides patient capital for early-stage companies focused on healthspan, performance, and longevity via scientific and accessible…
Stage
Pre-seed–Series B
Sectors
4 sectors
Cheque
$250k–$5m
Invests in
Not confirmed
Sectors
About
The firm supports early-stage companies that apply scientific knowledge to improve healthspan and performance. It focuses on the shift from reactive treatment to disease prevention, targeting the health, wellness, and food markets. Using long-term capital, the team collaborates with strategic partners and institutional networks to scale health products. The community integrates academic resources and scientific expertise to bring evidence-based solutions to consumers and healthcare providers.
How to approach
Connect with the team through the website if interested in growth, partnerships, or collaboration.